Pharmacogenetic considerations in the treatment of Parkinson's disease.
Neurodegener Dis Manag. 2015;5(1):27-35. doi: 10.2217/nmt.14.38.
Neurodegener Dis Manag. 2015.
PMID: 25711452
Review.